Nurix Therapeutics Statistics
Total Valuation
NRIX has a market cap or net worth of $1.22 billion. The enterprise value is $1.00 billion.
| Market Cap | 1.22B |
| Enterprise Value | 1.00B |
Important Dates
The next estimated earnings date is Thursday, July 11, 2024, after market close.
| Earnings Date | Jul 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NRIX has 64.36 million shares outstanding. The number of shares has increased by 1.62% in one year.
| Shares Outstanding | 64.36M |
| Shares Change (YoY) | +1.62% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 86.26% |
| Float | 41.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.06 |
| Forward PS | 16.30 |
| PB Ratio | 7.22 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.86 |
| Quick Ratio | n/a |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.10% and return on invested capital (ROIC) is -79.50%.
| Return on Equity (ROE) | -67.10% |
| Return on Assets (ROA) | -43.60% |
| Return on Capital (ROIC) | -79.50% |
| Revenue Per Employee | $284,813 |
| Profits Per Employee | -$509,623 |
| Employee Count | 284 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRIX has paid $90,000 in taxes.
| Income Tax | 90,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +88.17% in the last 52 weeks. The beta is 2.17, so NRIX's price volatility has been higher than the market average.
| Beta (5Y) | 2.17 |
| 52-Week Price Change | +88.17% |
| 50-Day Moving Average | 15.92 |
| 200-Day Moving Average | 11.02 |
| Relative Strength Index (RSI) | 54.80 |
| Average Volume (20 Days) | 1,321,076 |
Short Selling Information
The latest short interest is 7.60 million, so 11.81% of the outstanding shares have been sold short.
| Short Interest | 7.60M |
| Short Previous Month | 7.39M |
| Short % of Shares Out | 11.81% |
| Short % of Float | 18.20% |
| Short Ratio (days to cover) | 7.69 |
Income Statement
In the last 12 months, NRIX had revenue of $80.89 million and -$144.73 million in losses. Loss per share was -$2.66.
| Revenue | 80.89M |
| Gross Profit | 80.89M |
| Operating Income | -157.33M |
| Pretax Income | -144.64M |
| Net Income | -144.73M |
| EBITDA | -130.28M |
| EBIT | -144.64M |
| Loss Per Share | -$2.66 |
Balance Sheet
The company has $244.89 million in cash and $29.16 million in debt, giving a net cash position of $215.74 million or $3.35 per share.
| Cash & Cash Equivalents | 244.89M |
| Total Debt | 29.16M |
| Net Cash | 215.74M |
| Net Cash Per Share | $3.35 |
| Equity (Book Value) | 168.75M |
| Book Value Per Share | 2.62 |
| Working Capital | 163.35M |
Cash Flow
In the last 12 months, operating cash flow was -$74.86 million and capital expenditures -$9.01 million, giving a free cash flow of -$83.87 million.
| Operating Cash Flow | -74.86M |
| Capital Expenditures | -9.01M |
| Free Cash Flow | -83.87M |
| FCF Per Share | -$1.53 |
Margins
Gross margin is 100.00%, with operating and profit margins of -194.51% and -178.93%.
| Gross Margin | 100.00% |
| Operating Margin | -194.51% |
| Pretax Margin | -178.82% |
| Profit Margin | -178.93% |
| EBITDA Margin | -161.07% |
| EBIT Margin | -178.82% |
| FCF Margin | -103.69% |
Dividends & Yields
NRIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.62% |
| Shareholder Yield | -1.62% |
| Earnings Yield | -11.88% |
| FCF Yield | -6.88% |
Analyst Forecast
The average price target for NRIX is $25.10, which is 32.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.10 |
| Price Target Difference | 32.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 31.17% |
| EPS Growth Forecast (5Y) | -10.43% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NRIX has an Altman Z-Score of 1.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 2 |